Zepp Health (ZEPP) Competitors $48.53 -12.74 (-20.79%) Closing price 10/10/2025 03:59 PM EasternExtended Trading$48.52 -0.01 (-0.02%) As of 10/10/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZEPP vs. DBD, VYX, PAR, ATEN, EVLV, SSYS, CRSR, CTLP, ALLT, and KOPNShould you be buying Zepp Health stock or one of its competitors? The main competitors of Zepp Health include Diebold Nixdorf (DBD), NCR Voyix (VYX), PAR Technology (PAR), A10 Networks (ATEN), Evolv Technologies (EVLV), Stratasys (SSYS), Corsair Gaming (CRSR), Cantaloupe (CTLP), Allot (ALLT), and Kopin (KOPN). These companies are all part of the "computer hardware" industry. Zepp Health vs. Its Competitors Diebold Nixdorf NCR Voyix PAR Technology A10 Networks Evolv Technologies Stratasys Corsair Gaming Cantaloupe Allot Kopin Diebold Nixdorf (NYSE:DBD) and Zepp Health (NYSE:ZEPP) are both computer hardware companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership. Is DBD or ZEPP more profitable? Diebold Nixdorf has a net margin of -0.35% compared to Zepp Health's net margin of -38.81%. Diebold Nixdorf's return on equity of 7.92% beat Zepp Health's return on equity.Company Net Margins Return on Equity Return on Assets Diebold Nixdorf-0.35% 7.92% 2.20% Zepp Health -38.81%-24.19%-11.36% Which has more risk and volatility, DBD or ZEPP? Diebold Nixdorf has a beta of 1.59, indicating that its stock price is 59% more volatile than the S&P 500. Comparatively, Zepp Health has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Do institutionals and insiders have more ownership in DBD or ZEPP? 97.0% of Diebold Nixdorf shares are owned by institutional investors. Comparatively, 52.6% of Zepp Health shares are owned by institutional investors. 0.3% of Diebold Nixdorf shares are owned by company insiders. Comparatively, 36.0% of Zepp Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media prefer DBD or ZEPP? In the previous week, Diebold Nixdorf had 4 more articles in the media than Zepp Health. MarketBeat recorded 8 mentions for Diebold Nixdorf and 4 mentions for Zepp Health. Diebold Nixdorf's average media sentiment score of 0.41 beat Zepp Health's score of 0.12 indicating that Diebold Nixdorf is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Diebold Nixdorf 2 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Zepp Health 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings and valuation, DBD or ZEPP? Diebold Nixdorf has higher revenue and earnings than Zepp Health. Diebold Nixdorf is trading at a lower price-to-earnings ratio than Zepp Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDiebold Nixdorf$3.75B0.54-$16.50M-$0.34-161.59Zepp Health$182.60M3.85-$75.73M-$4.83-10.05 Do analysts prefer DBD or ZEPP? Diebold Nixdorf currently has a consensus target price of $75.00, indicating a potential upside of 36.51%. Zepp Health has a consensus target price of $60.23, indicating a potential upside of 24.11%. Given Diebold Nixdorf's stronger consensus rating and higher probable upside, equities analysts plainly believe Diebold Nixdorf is more favorable than Zepp Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Diebold Nixdorf 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75Zepp Health 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryDiebold Nixdorf beats Zepp Health on 14 of the 17 factors compared between the two stocks. Get Zepp Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEPP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZEPP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZEPP vs. The Competition Export to ExcelMetricZepp HealthMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$704.22M$2.21B$6.02B$21.47BDividend YieldN/AN/A5.67%3.65%P/E Ratio-10.0537.4686.0328.89Price / Sales3.8542.19531.0261.65Price / CashN/A62.0437.2623.41Price / Book2.7812.8112.754.51Net Income-$75.73M-$63.46M$3.31B$1.01B7 Day Performance-1.85%-2.84%0.79%-3.53%1 Month Performance-3.45%3.50%6.67%-1.39%1 Year Performance1,310.76%38.28%77.62%10.40% Zepp Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZEPPZepp Health1.7081 of 5 stars$48.53-20.8%$60.23+24.1%+1,310.8%$704.22M$182.60M-10.051,230Analyst ForecastHigh Trading VolumeDBDDiebold Nixdorf4.3629 of 5 stars$58.31+0.2%$75.00+28.6%+19.6%$2.13B$3.75B-171.4921,000News CoverageAnalyst ForecastVYXNCR Voyix3.1118 of 5 stars$12.54-1.8%$15.57+24.2%-16.0%$1.77B$2.83B1.7614,000Analyst UpgradePARPAR Technology2.2642 of 5 stars$37.91-2.0%$78.43+106.9%-36.1%$1.57B$349.98M-16.851,585News CoverageAnalyst ForecastATENA10 Networks3.6431 of 5 stars$18.66+1.9%$22.00+17.9%+19.1%$1.32B$261.70M27.44580Analyst ForecastEVLVEvolv Technologies1.8783 of 5 stars$7.49+0.4%$8.88+18.5%+102.2%$1.28B$103.86M-13.62170Analyst ForecastSSYSStratasys2.8945 of 5 stars$11.88+2.1%$14.33+20.7%+43.3%$990.49M$572.46M-8.871,779News CoverageAnalyst ForecastAnalyst RevisionCRSRCorsair Gaming4.185 of 5 stars$7.97-0.7%$9.86+23.7%+7.9%$851.48M$1.32B-9.842,567Analyst ForecastCTLPCantaloupe3.2128 of 5 stars$10.60+0.3%$12.55+18.4%+14.8%$775.51M$302.55M13.42220Analyst ForecastALLTAllot1.1661 of 5 stars$11.21+5.3%N/A+238.8%$495.32M$92.19M-224.20740News CoverageAnalyst ForecastKOPNKopin1.0064 of 5 stars$3.57+26.6%$3.00-16.0%+308.6%$459.11M$50.33M-39.67180News CoverageAnalyst ForecastGap UpHigh Trading Volume Related Companies and Tools Related Companies Diebold Nixdorf Alternatives NCR Voyix Alternatives PAR Technology Alternatives A10 Networks Alternatives Evolv Technologies Alternatives Stratasys Alternatives Corsair Gaming Alternatives Cantaloupe Alternatives Allot Alternatives Kopin Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ZEPP) was last updated on 10/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zepp Health Corporation Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Zepp Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
